Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BioNTech SE - American Depositary Shares
(NQ:
BNTX
)
90.58
-2.27 (-2.44%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BioNTech SE - American Depositary Shares
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
72
73
Next >
Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna Slip
↗
January 27, 2023
The FDA's experts voted in favor of annual boosters on Thursday.
Via
Investor's Business Daily
Mergers and Acquisitions in 2023 Off To A Strong Start
January 26, 2023
Mergers and acquisitions are common, especially across the health sector. Here are some lesser-known buyouts and how they could fare down the road.
Via
MarketBeat
Thursday Predictions: 3 Hot Stocks for Tomorrow
↗
January 25, 2023
Airline stocks, credit card stocks, and vaccine stocks are our focus when it comes to the hot stocks for tomorrow. Here's why.
Via
InvestorPlace
Analyst Ratings for BioNTech
↗
January 24, 2023
Via
Benzinga
COVID-19 Vaccine Strategy Might Follow The Influenza Shot Way, FDA To Decide Today
↗
January 23, 2023
The FDA is considering a significant shift in the U.S.'s COVID-19 vaccine strategy to simplify vaccination against COVID-19.
Via
Benzinga
BioNTech Starts Dosing In Herpes Vaccine Candidate Study
↗
December 21, 2022
Via
Benzinga
Will Investors Notice Exciting Sign On BioNTech's Chart?
↗
December 19, 2022
Via
Benzinga
Google Layoffs 12K Employees, Netflix's Q4 Earnings And CEO Steps Down, FDA Rejects Eli Lilly's Alzheimer's Candidate: Top Stories Friday, Jan. 20
↗
January 20, 2023
Here's a round-up of stories from around the globe and from various media outlets. Benzinga
Via
Benzinga
Israel Says No Stroke Risk Associated With Pfizer/BioNTech Updated COVID-19 Shots
↗
January 20, 2023
Israel health ministry official said Isreal had not identified any evidence linking strokes to an updated coronavirus vaccine by Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX).
Via
Benzinga
Pfizer (PFE) Stock Falls on Analyst Downgrade
↗
January 17, 2023
Although Pfizer led the charge in forwarding Covid-19 solutions, possibly waning relevancy poses serious concerns for PFE stock.
Via
InvestorPlace
Pfizer Stock Dives As Analyst Calls For 'Covid Reset' And Downgrades Shares
↗
January 17, 2023
Shares have skidded almost 10% in the first two weeks of 2023.
Via
Investor's Business Daily
US Health Agencies Investigate Preliminary COVID-19 Vaccine Safety Signal In Older People
↗
January 16, 2023
The U.S.
Via
Benzinga
Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot
↗
January 13, 2023
Johnson & Johnson (NYSE: JNJ) has significantly scaled back its efforts of manufacturing its COVID-19 vaccine after facing a fall in demand.
Via
Benzinga
Nice Gains During JPM23 Week: Benign CPI Report Brings Hope For A “Soft Landing”
↗
January 12, 2023
Small-cap speculative biotech stocks regain interest with volatility.
Via
Talk Markets
BioNTech Strengthens Its Artificial Intelligence With Acquisition Of British Startup
↗
January 10, 2023
Via
Benzinga
BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development
January 10, 2023
From
BioNTech SE
Via
GlobeNewswire
Israel Based Study Shows Omicron Adapted Vaccine Shots Cut Hospitalization Rates In Elderly
↗
January 09, 2023
Israel based real-world study shows that omicron-targeted COVID-19 vaccine from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) reduced hospitalizations among older patients.
Via
Benzinga
CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks
↗
January 06, 2023
Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too.
Via
Investor's Business Daily
2 Top Biotech Stocks to Buy Right Now
↗
January 06, 2023
These two pharmaceutical companies pay market-beating dividends to shareholders.
Via
The Motley Fool
BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030
January 05, 2023
From
BioNTech SE
Via
GlobeNewswire
Valneva Touts Additional Positive Heterologous Booster Data From COVID-19 Vaccine Study
↗
January 03, 2023
Via
Benzinga
Why BioNTech Was a Sickly Stock This Week
↗
December 30, 2022
The world is trying hard to get past the coronavirus pandemic, and investors are trying hard to get past coronavirus stocks.
Via
The Motley Fool
BioNTech to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 28, 2022
From
BioNTech SE
Via
GlobeNewswire
Three Pharma Stocks to Sell Before They Die
↗
December 24, 2022
As we head into New Year 2023, these are just some of the top pharma stocks to sell at the start of January.
Via
InvestorPlace
BioNTech Initiates Phase 1 Clinical Trial for Malaria Vaccine Program BNT165
December 23, 2022
From
BioNTech SE
Via
GlobeNewswire
BioNTech and Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccination of German Expatriates in China
December 22, 2022
From
BioNTech SE
Via
GlobeNewswire
Update on First BioNTainer for African-based mRNA Manufacturing Facility
December 21, 2022
From
BioNTech SE
Via
GlobeNewswire
BioNTech Starts Phase 1 Clinical Trial for Prophylactic Herpes Simplex Virus-2 Vaccine Candidate BNT163
December 21, 2022
From
BioNTech SE
Via
GlobeNewswire
The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond
↗
December 18, 2022
These seven hottest healthcare stocks have strong growth catalysts that could send each of them higher over the next few years.
Via
InvestorPlace
Market Rally Pressured On Fed Rate Outlook; Moderna, Boeing, Tesla In Focus: Weekly Review
↗
December 16, 2022
Moderna spiked on a cancer vaccine while Tesla continued to dive.
Via
Investor's Business Daily
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
72
73
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
